CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.73%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.04B
AUM Growth
+$7.04B
(+6.8%)
Cap. Flow
+$73.9M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
69.19%
Holding
135
New
6
Increased
55
Reduced
52
Closed
9
Top Buys
| 1 |
Citigroup
C
|
$55.6M |
| 2 |
Visa
V
|
$20.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$12.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$11.6M |
Top Sells
| 1 |
Home Depot
HD
|
$40.1M |
| 2 |
Nike
NKE
|
$11.2M |
| 3 |
Mondelez International
MDLZ
|
$11.1M |
| 4 |
Centene
CNC
|
$10.6M |
| 5 |
Colgate-Palmolive
CL
|
$10.6M |
Sector Composition
| 1 | Financials | 27.87% |
| 2 | Healthcare | 18.82% |
| 3 | Consumer Discretionary | 16.92% |
| 4 | Communication Services | 15.48% |
| 5 | Materials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
76
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.23M | 0.05% |
31,863
+4,765
| +18% | +$484K |
|
77
Coherus Oncology, Inc. Common Stock
CHRS
$143M
| $3.19M | 0.05% |
238,971
-2,534
| -1% | -$33.8K |
|
|
OXFD
78
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $3.08M | 0.04% |
183,235
+1,087
| +0.6% | +$18.3K |
|
79
Acadia Healthcare
ACHC
$2.17B
| $3.02M | 0.04% |
63,305
+9,305
| +17% | +$444K |
|
80
Puma Biotechnology
PBYI
$266M
| $2.85M | 0.04% |
23,792
-16,042
| -40% | -$1.92M |
|
81
Supernus Pharmaceuticals
SUPN
$2.52B
| $2.85M | 0.04% |
71,143
-527
| -0.7% | -$21.1K |
|
82
DexCom
DXCM
$30.1B
| $2.78M | 0.04% |
56,835
-4,260
| -7% | -$208K |
|
83
Bausch Health
BHC
$2.77B
| $2.78M | 0.04% |
193,908
-3,102
| -2% | -$44.5K |
|
84
NeoGenomics
NEO
$1.1B
| $2.72M | 0.04% |
244,300
-1,700
| -0.7% | -$18.9K |
|
|
TSRO
85
DELISTED
TESARO, Inc.
TSRO
| $2.7M | 0.04% |
20,916
-25,816
| -55% | -$3.33M |
|
|
HIND
86
Vyome Holdings, Inc. Common Stock
HIND
$227M
| $2.63M | 0.04% |
276,211
+33,318
| +14% | +$317K |
|
87
Toronto Dominion Bank
TD
$128B
| $2.62M | 0.04% |
37,332
| – | – |
|
88
Aclaris Therapeutics
ACRS
$219M
| $2.49M | 0.04% |
96,300
-300
| -0.3% | -$7.75K |
|
89
Snap-on
SNA
$16.8B
| $2.31M | 0.03% |
15,507
+2,830
| +22% | +$422K |
|
90
Algonquin Power & Utilities
AQN
$4.35B
| $2.22M | 0.03% |
167,900
-96,100
| -36% | -$1.27M |
|
|
ELGX
91
DELISTED
Endologix Inc
ELGX
| $2.2M | 0.03% |
493,325
-7,681
| -2% | -$34.3K |
|
|
AFAM
92
DELISTED
Almost Family Inc
AFAM
| $2.05M | 0.03% |
38,200
+14,200
| +59% | +$762K |
|
93
Open Text
OTEX
$8.33B
| $1.96M | 0.03% |
48,700
+19,300
| +66% | +$777K |
|
|
FSTX
94
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $1.87M | 0.03% |
111,200
+86,077
| +343% | +$1.45M |
|
95
CVS Health
CVS
$93B
| $1.83M | 0.03% |
22,470
| – | – |
|
|
STML
96
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.78M | 0.03% |
+160,000
| New | +$1.78M |
|
97
Mastercard
MA
$536B
| $1.74M | 0.02% |
12,300
-7,519
| -38% | -$1.06M |
|
98
Ingredion
INGR
$8.19B
| $1.65M | 0.02% |
13,700
| – | – |
|
99
Heron Therapeutics
HRTX
$207M
| $1.62M | 0.02% |
+100,000
| New | +$1.62M |
|
100
Zevra Therapeutics
ZVRA
$517M
| $1.61M | 0.02% |
435,528
+53,829
| +14% | +$199K |
|